Rigel Pharmaceuticals Gets No Boost From FDA Approval
Rigel Pharmaceuticals shares retreated early Wednesday despite an approval from the FDA for its treatment of thrombocytopenia.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 1384 Red-Hot Biotech Stocks to Buy Before Earnings
These four top Suntrust biotech picks for 2018 all have the potential for big upside moves if they do indeed exceed first-quarter expectations.
Why GW Pharmaceuticals Could Be an FDA First
GW Pharmaceuticals shares saw a solid gain on Tuesday after the FDA released some briefing documents pertaining to an upcoming approval meeting. Needless to say, investors are taking this as a positive sign.
Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?
Rheumatoid arthritis is an autoimmune disease that attacks tissues within the joints, and it is a major target of U.S. and foreign biotechnology and pharmaceutical companies.
Why Now Is the Best Time for Bellicum to Raise Cash
Bellicum Pharmaceuticals shares pulled back on Tuesday after the firm announced that it would be conducting a secondary offering to raise some cash.
An Upcoming Drug May Emerge as the Winner in the War on Chronic Severe Gout
Many of the gout treatments on the market have been the same for decades, and many of them can come with their own sets of adverse side effects.
Breast Cancer Drug Can Bring Exponential Sales Growth for Puma Biotechnology
The world of biotech can be a rags-to-riches story for companies that build up a drug candidate and secure FDA approval for that drug. And the larger the drug target group is, the more…
Johnson & Johnson Earnings Just Par for the Course
Johnson & Johnson (NYSE: JNJ) reported its first quarter financial results before the markets opened on Tuesday. The company said that it had $2.06 in earnings per share (EPS) on $20.01 billion in revenue,…
Why UnitedHealth Is Boasting Healthy Earnings
UnitedHealth released a better-than-expected quarterly earnings report before the markets opened on Tuesday.
Merck Wins Big Against Rivals in Lung Cancer Study Survival Rates
Lung cancer may have just met a new standard of care. On top of that, it would be considered a new standard as a first line of care in lung cancer and longer overall survival rates.
Why NewLink Genetics Shares Hit an All-Time Low
NewLink Genetics shares hit an all-time low in Monday’s session after the company provided an update on its brain tumor trial.
Alkermes Wins Big on FDA Approval
Shares of Alkermes saw a handy gain to start out the week after the FDA made a critical decision about its treatment for major depressive disorder.
Why Celldex Therapeutics Is Getting Crushed
Celldex Therapeutics shares were absolutely crushed on Monday morning after the firm announced results to its midstage breast cancer study.
Why 4 Top Biotech Stocks May Be the Next Takeover Targets
These four top companies could be very attractive to large cap biotechs looking to add gene and cell therapy drugs to their portfolios.
6 Biotech and Medtech Stocks That Saw Massive Moves Last Week
Over the past week, a few biotech companies made absolutely massive runs, while others fell off a cliff. Although health care has barely kept pace with the broader markets over the past 52 weeks,…